GSK shares drag FTSE 100 as company faces multi-billion pound bill following Zantac trial decision
Monday, June 03, 2024 at 1:00 p.m Lawsuits could become a multi-billion dollar headache for GSK GSK shares fell this morning after a US court ruled on Friday that it will have to face a jury trial over the potential cancer properties of its heartburn pharmaceutical Zantac. On Friday, a Delaware judge allowed almost 80,000 … Read more